RESTART LIFE SCIENCES — Board/Management Information 2024

Dec 11, 2024

PRESS RELEASE

Restart Life adds Marketing Professional in Health and Wellness to its Board

VANCOUVER, BC / December 10, 2024 / Restart Life Science Corp. (CSE: HEAL) (FSE: HN3) (OTC Pink Sheets: NMLSD) ("HEAL" or the "Company") is pleased to announce the addition of Khavita Harrycharran to its Board of Directors.

Ms. Harrycharran is a seasoned marketing professional with extensive experience in account management within the health and wellness sectors. With a proven track record of delivering strategic results and exceptional productization delivery, all while maintaining disciplined financial oversight. Ms. Harrycharran specializes in fostering strong client relationships and orchestrating cross-functional teams to execute impactful marketing campaigns.

Ms. Harrycharran currently manages a diverse portfolio of multiple accounts and plays a pivotal role in aligning client objectives with comprehensive marketing strategies, reflecting a deep understanding of the unique needs and nuances of each client. Whether it's overseeing product launches, brand repositioning, or multi-channel advertising campaigns, Ms. Harrycharran consistently ensures that each project exceeds client expectations while driving measurable results.

Passionate about the dynamic worlds of health and wellness, Ms. Harrycharran remains committed to staying ahead of industry trends, leveraging data-driven insights, and delivering exceptional service that builds lasting partnerships.

With this addition, Derek Ivany has resigned from the Board of Directors and as Executive Chair. The Company wishes him success in his future endeavors. Steve Loutskou, President, CEO and a Director of the Company, shall assume Mr. Ivany's role as Executive Chair.

About Restart Life Sciences Corp.

Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life., please visit the Company's website at www.restartlife.co

Forward-Looking Statements

This news release contains statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Science's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking

---

PRESS RELEASE

statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the board of directors
Chief Executive Officer - Steve Loutskou
Tel: +1 (778) 819-0244
Email: info@restartlife.co